Khosla Ventures invests in companies that are bold, early, and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs. Khosla Ventures invests in a range of areas including AI, climate, sustainability, enterprise, consumer, fintech, digital health, medtech and diagnostics, therapeutics, and frontier technology.

Khosla Ventures

BlueRun Ventures is a venture capital firm with offices in the United States, Shanghai, Beijing, and Korea. BlueRun invests in information technology, mobile, and consumer technologies, with an emphasis on mobile opportunities.  BRV has invested in over 160 companies, with select exits from PayPal (acquired by eBay), Waze (acquired by Google), Topsy (acquired by Apple), Coupa (NASDAQ: COUP), and more.  In 2005, BlueRun changed its name from Nokia Venture Partners. While branded as Nokia Venture Partners, the firm helped to build emerging market leaders such as Airgo, Bitfone, Cornice, PayPal, Wavemarket, and WiderThan.

BlueRun Ventures

Resolute is focused on finding extraordinary entrepreneurs and helping them succeed over the course of their career. Because our approach is so entrepreneur-focused, we are comfortable investing at the earliest of stages, often before any other investors. We make investment decisions quickly.  Very soon after our first meeting, we will either pass or articulate a discrete roadmap to a decision. We will invest as little as $50k and as much as $750k in a company’s initial financing. We prefer being a lead investor and guiding our entrepreneurs to the key milestones for a successful venture round.   We dislike “headless” seed rounds that lack a lead investor. Post investment we immediately focus on ensuring these milestones are clearly defined, and work to help our entrepreneurs achieve them. Rinse and repeat.

Resolute Ventures

AAF Management Ltd. (AAF) is a leading early-stage venture capital firm focused on pre-Seed, Seed and Series A stage technology companies in North America. Since late 2016, we’ve invested in over 120 venture-backed portfolio companies across fintech, healthcare, consumer, enterprise software and deep tech.  We are backed by over 95 Limited Partners (LPs) across two funds. Our investors include leading multi-family offices, single family offices, royal families, c- level executives, ministers, ambassadors, fund-of-funds, foundations, hedge fund managers and other strategic investors across the US, Europe, and MENA region.    We also actively manage Limited Partnership (LP) allocations into early stage emerging managers globally exposing us to over 600 venture-backed companies. We’ve backed emerging managers who were previous venture investors at prestigious firms such as Sequoia Capital, Lightspeed Ventures, NEA, Khosla Ventures, Kleiner Perkins among others.  Notable companies in our extended portfolio include: Deel, Ramp, Robinhood, Didi, Savage X by Fenty, StockX, Figure, Reddit, Current, Synthego, Epic Games, FiscalNote among many others.  Notable exits in our extended portfolio include: CrowdStrike (NASDAQ: CRWD), TruOptik acq. by Transunion (NYSE: TRU), Prodigy acq. by Upstart (NASDAQ: UPST), Portfolium acq. by Instructure (NYSE: INST), now a Thoma Bravo Company, HeyDoctor acq. by GoodRx (NYSE: GDRX), Finmark acq. by Bill.com(NYSE: BILL) among others.

AAF Management Ltd.

Maven is a seed stage venture firm investing in tech companies addressing emerging consumer behavior and trends. The Maven team identifies and backs bold founders with a vision worth fighting for, then helps founders unlock their potential to change the world, building iconic brands like Zoom and Cruise. Maven maintains a concentrated investment strategy, making only 6-8 core investments each year. 16% of Maven companies have achieved an exit or valuation at $500M or more, 10x industry average.

Maven Ventures

IVP turns breakout companies into enduring market leaders. With a 40-year record of driving growth and 130+ IPOs, we’ve partnered with over 400 companies including Amplitude, Brex, Coinbase, Crowdstrike, Datadog, Discord, Klarna, Slack, Snap, and Twitter. As trusted allies, IVP helps founders and CEOs meet the challenge of leading a rapidly growing company. Its proven system bolsters functions including those that are sometimes overlooked and partners serve as trusted allies to companies seeking to realize their full potential.

Stripes is a growth equity firm that invests in software and consumer businesses. Stripes’ software practice invests in leading horizontal and vertical software platforms servicing customers from SMB to Enterprise. It was founded in 2008 and headquartered in New York, United States.

Stripes

Transform Capital is a traditional late-stage venture capital fund with a unique approach to impact. We invest in high-growth, revenue generating technology companies and donate 50% of General Partners’ profits to causes selected by Transform investors and founders.

Transform Capital

Hello Heart

Hello Heart is a best in class solution that empowers people to understand and improve their heart health - the #1 cost factor for employers. The program is clinically based and targets people with high blood pressure. Each of our users receives a wireless blood pressure monitor and real-time personalized tips on their smartphone. It is easy to use and helps participants improve their heart health in a fun and engaging way.

Hello Heart is an AI-powered chronic care management startup that focuses on hypertension self-management via a mobile app. Members who sign up receive a free wireless blood-pressure monitor that connects to the Hello Heart app, allowing them to track their blood pressure, diabetes, and cholesterol levels. Users also receive personalized feedback on their readings along with suggestions to improve their health. Patients can also track activity levels and medication adherence through the app. In <a href="https://sp-edge.com/updates/12734">August 2022</a>, the company launched a new feature called “My Cholesterol” focusing on cholesterol management using AI capabilities.

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

Hello Heart on LinkedIn: #menshealthmonth #menshealth #hearthealth #cvd

Hello Heart is an AI-powered chronic care management startup that focuses on hypertension self-management via a mobile app. Members who sign up receive a free wireless blood-pressure monitor that connects to the Hello Heart app, allowing them to track their blood pressure, diabetes, and cholesterol levels. Users also receive personalized feedback on their readings along with suggestions to improve their health. Patients can also track activity levels and medication adherence through the app. In <a href="https://sp-edge.com/updates/12734">August 2022</a>, the company launched a new feature called “My Cholesterol” focusing on cholesterol management using AI capabilities.Key customers and partnershipsThe company operates in the B2B2C employer-sponsored market. It claims its solution lowers medical costs by 19% in the first year for members (up to USD 2,834 per person savings). As of February 2024, the company had over 110 partners. Additionally, CVS Health added Hello Heart to its Point Solutions Management platform.Funding and financialsThe company’s latest funding round took place in <a href="https://sp-edge.com/updates/10102">May 2022</a> when it raised USD 70 million in a Series D funding round led by Stripes. The round took place a year after the firm announced its USD 45 million Series C round in 2021. The funds were allocated to enhance its AI capabilities for managing heart health including whole heart health functionality as well as expanding its offering into hyperlipidemia (high cholesterol) management.Furthermore, in 2023, the company’s revenue grew by 100%.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

<div>
 Hello Heart, an app-based heart health management company, has hired Assaf Ohana as its inaugural Chief Product Officer (CPO). Before this role, Ohana served as CPO at ActiveFence and Alto Pharmacy. He also provided his expertise at notable platforms such as Instacart and Upwork, playing a key role in the development of influential digital platforms.
</div>

Hello Heart

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless